BIOA NASDAQ
Credit Risk of going bust: higher than 72% of companies Debt: 1.4% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.02 (down 99.7%), BioAge Labs Inc. would be worth roughly what it owes.
Total debt $2.8M against a stock market value of $205.9M.
Distance to default 3.26 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.4M (short-term plus half of long-term), stock volatility 129.6%; Altman Z'' 18.29. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Emeryville, CA 94608
US
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The companyâs technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Barton Shane | M-Exempt | 4,290 | $10.85 | 2026-06-30 |
| Barton Shane | M-Exempt | 4,000 | $8.39 | 2026-06-30 |
| Barton Shane | S-Sale | 20,216 | $25.19 | 2026-06-30 |
| Barton Shane | M-Exempt | 4,290 | $10.85 | 2026-06-30 |
| Barton Shane | M-Exempt | 4,000 | $8.39 | 2026-06-30 |